Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: A Randomized Controlled Pilot Trial

NCT05639322 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT05639322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05639322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: A Randomized Controlled Pilot Trial
Lead sponsor
Unity Health Toronto
Phase
Phase 4
Overall status
Completed
Start date
October 12, 2023
Completion date
July 24, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain